Stock listing
ABCL Stock Price, News, Filings & Events — Abcellera Biologics Inc.
Selected listing: ABCL · BX · CHF · CH
This page tracks Abcellera Biologics Inc.'s ABCL:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ABCL:BX. ABCL:BX is the stock-level entry point for investors researching Abcellera Biologics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Abcellera Biologics Inc. is a public company traded under the ticker ABCL in the American market. The company has a market capitalization of approximately $1.97 billion. Abcellera focuses on advancing its proprietary technology for antibody discovery and development.
- Ticker
- ABCL:BX
- Asset type
- Stock
- Market cap
- $3.67B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BX
- Currency
- CHF
Abcellera Biologics Inc. ABCL:BX stock context
This page tracks Abcellera Biologics Inc.'s ABCL:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ABCL:BX. ABCL:BX is the stock-level entry point for investors researching Abcellera Biologics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Abcellera Biologics Inc. is a public company traded under the ticker ABCL in the American market. The company has a market capitalization of approximately $1.97 billion. Abcellera focuses on advancing its proprietary technology for antibody discovery and development.
Latest news from Abcellera Biologics Inc.
AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants
August 13, 2026
AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Se...
August 10, 2026
AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on ...
August 7, 2026
AbCellera Biologics : Q2 2026 Business Update Presentation
August 5, 2026
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
July 29, 2026
Research Abcellera Biologics Inc.
Abcellera Biologics Inc. investor report
Review AI stock analysis and investor report context for ABCL:BX.
Abcellera Biologics Inc. company profile
View the public company page for Abcellera Biologics Inc. on 6ix.
Abcellera Biologics Inc. news
Read company news and market updates connected to Abcellera Biologics Inc..
Abcellera Biologics Inc. investor events
Find investor webinars, events, and replay context for Abcellera Biologics Inc..
Alternate listings
ABCL:NASDAQ
US · USD
Alternate listing for Abcellera Biologics Inc.; the primary context on this page is ABCL:BX.
8QQ:GETTEX
DE · EUR
Alternate listing for Abcellera Biologics Inc.; the primary context on this page is ABCL:BX.
8QQ:TRADEGATE
DE · EUR
Alternate listing for Abcellera Biologics Inc.; the primary context on this page is ABCL:BX.
A2QKXS:LSX
DE · EUR
Alternate listing for Abcellera Biologics Inc.; the primary context on this page is ABCL:BX.
ABCL:BOATS
US · USD
Alternate listing for Abcellera Biologics Inc.; the primary context on this page is ABCL:BX.
A2QKXS:LS
DE · EUR
Alternate listing for Abcellera Biologics Inc.; the primary context on this page is ABCL:BX.
8QQ:FWB
DE · EUR
Alternate listing for Abcellera Biologics Inc.; the primary context on this page is ABCL:BX.
8QQ:DUS
DE · EUR
Alternate listing for Abcellera Biologics Inc.; the primary context on this page is ABCL:BX.
8QQ:HAM
DE · EUR
Alternate listing for Abcellera Biologics Inc.; the primary context on this page is ABCL:BX.
8QQ:MUN
DE · EUR
Alternate listing for Abcellera Biologics Inc.; the primary context on this page is ABCL:BX.
8QQ:SWB
DE · EUR
Alternate listing for Abcellera Biologics Inc.; the primary context on this page is ABCL:BX.